Using the same expertise they’ve employed to build new organs for patients, scientists at Wake Forest Institute for Regenerative Medicine and colleagues have engineered micro hearts, lungs and livers that can potentially be used to test new drugs. By combining the micro-organs in a monitored system, the researchers aim to mimic how the human body responds to medications.
The goal of the effort, known as a “body-on-a-chip,” is to help reduce the estimated $2 billion price tag and 90 percent failure rate that pharmaceutical companies face when developing new medications. Drug compounds are currently screened in the lab using human cells and then tested in animals. But neither of these methods adequately replicates how drugs affect human organs.
“There is an urgent need for improved systems to accurately predict the effects of drugs, chemicals and biological agents on the human body,” said Anthony Atala, M.D., director of the institute and senior researcher on the multi-institution body on a chip project, funded by the Defense Threat Reduction Agency.
In Scientific Reports, published by Nature, the research team reports success engineering micro-sized 3D organs, known as organoids, and connecting them together on a single platform to monitor their function. While other teams have combined cells from multiple organs in a similar system, this is the first reported success using 3D organ structures, known to be higher functioning and to more accurately model the human body.
The organ structures were made from cell types found in native human tissue using 3D printing and other methods. Heart and livers were selected for the system because toxicity to these organs is a major reason for drug candidate failures and drug recalls. Lungs are the point of entry for toxic particles and also for aerosol drugs, such as asthma inhalers.
The organoids are placed in a sealed, monitored system – complete with real-time camera. A nutrient-filled liquid that circulates through the system keeps the organoids alive and is used to introduce potential drug therapies into the system.
The researchers first tested the organoids to ensure their similarity to human organs. For example, the micro-liver received a high dose of a common pain reliever – and then a different drug to counteract the toxic effects.
“The data show a significant toxic response to the drug as well as mitigation by the treatment, accurately reflecting the responses seen in human patients,” said Aleks Skardal, Ph.D., assistant professor at Wake Forest Institute for Regenerative Medicine, who represented the multi-investigator team as the lead author of the paper.
But more important than how an individual organ responds to drugs is how the body as a whole responds. In many cases during testing of new drug candidates – and sometimes even after the drugs have been approved for use – drugs have unexpected toxic effects in tissues not directly targeted by the drugs themselves.
“If you screen a drug in livers only, for example, you’re never going to see a potential side effect to other organs,” said Skardal. “By using a multi-tissue organ-on-a-chip system, you can hopefully identify toxic side effects early in the drug development process, which could save lives as well as millions of dollars.”
The scientists conducted multiple scenarios to ensure that the body-on-a- chip system mimics a multi-organ response. For example, they introduced a drug used to treat cancer into the system. Known to cause scarring of the lungs, the drug also unexpectedly affected the system’s heart. However, a control experiment using only the heart showed no response.
The scientists theorize that the drug caused inflammatory proteins from the lung to be circulated throughout the system. As a result, the heart increased beats and then later stopped altogether, indicating a toxic side effect.
“This was completely unexpected, but it’s the type of side effect that can be discovered with this system in the drug development pipeline,” Skardal said.
Scientists are working to increase the speed of the system for large scale screening, and also to add additional organs.
“Eventually we expect to demonstrate the utility of a body-on-a-chip system containing many of the key functional organs in the human body,” said Atala. “This system has the potential for advanced drug screening and also to be used in personalized medicine – to help predict an individual patient’s response to treatment.”
Learn more: Scientists Develop “Body-on- a-Chip” System to Accelerate Testing of New Drugs
The Latest on: Body-on-a-chip
[google_news title=”” keyword=”body-on-a-chip” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- Arm to launch AI division with new chips by 2025on May 13, 2024 at 6:30 am
Plus Foxconn defends Wisconsin efforts, Korea to spend on chips, and more Asia in brief SoftBank-owned Arm is reportedly preparing to add AI chips to its product portfolio starting in 2025.… The chip ...
- Elon Musk’s brain chip has sudden setbackon May 11, 2024 at 8:32 pm
Nueralink – a company owned by Elon Musk that produces implants intended to help patients with conditions such as quadriplegia – made a big step forward this year, but also hit a small setback.
- Chocolate Chip Quinoa Cookies Recipeon May 11, 2024 at 4:45 pm
The addition of cooked quinoa in these otherwise classic chocolate chip cookies adds nutrition and texture for a hybrid between light snack and rich dessert ...
- I was spending $4,000 a year on vodka — I quit drinking, lost half my body weight and just won my first triathlonon May 10, 2024 at 8:34 pm
A motivated man shed half his body weight and ditched a drinking habit costing him thousands of dollars a year — now he’s winning ultra-triathlons. Jonathan Perez, 28, had always been overweight, but ...
- Silvaco: Strong Public Offering For The Technology Behind The Chipon May 10, 2024 at 2:44 pm
Silvaco Group's shares have had a successful public offering, being priced at the high end of the range. Check out the reasons I am cautious on SVCO stock.
- Neuralink brain chip implant partially failed after surgeryon May 10, 2024 at 10:18 am
Neuralink Corporation, the controversial neurotechnology company criticized for its questionable medical trials resulting in the death of a significant number of monkeys, achieved its first ...
- 7 Blue-Chip Stocks to Sell in May Before They Crash & Burnon May 8, 2024 at 11:34 am
InvestorPlace - Stock Market News, Stock Advice & Trading Tips As we enter the tail end of first-quarter earnings season, clear winners and ...
- US chip body predicts national dominanceon May 8, 2024 at 3:44 am
The US-based SIA predicted a $52B funding programme would deliver a leading global position in the chip sector by 2032.
- Police say Kettering man was killed in his home; body ID'd via knee replacementon May 7, 2024 at 11:36 am
Police said the death of a Kettering man whose dismembered body parts were found at two locations in Trotwood is believed to be a homicide that happened in the victim's Croftshire Drive home. Edgar S.
- Chip Roy demands sanctions on ICC officials going after US, Israelon May 7, 2024 at 10:00 am
House GOP lawmakers are pushing for a new bill to force President Biden to sanction ICC officials who go after Americans or U.S. allies.
via Google News and Bing News